JNJ-26483327

Product Name: JNJ-26483327
Description: JNJ-26483327, also known as BGB102, is an orally bioavailable, small-molecule, multitargeted reversible tyrosine kinase inhibitor with potential antineoplastic activity. Multitargeted tyrosine kinase inhibitor JNJ-26483327 binds to and inhibits several me
CAS NO: 77591-33-4 Product: Thymosin beta 4
Synonym: JNJ26483327; JNJ 26483327; JNJ-26483327; BGB102; BGB-102; BGB 102.
IUPAC Chemical Name: 35-bromo-17-methoxy-5-methyl-11-oxa-2,5-diaza-1(4,6)-quinazolina-3(1,2)-benzenacycloundecaphane
In ChiKey: JXDYOSVKVSQGJM-UHFFFAOYSA-NHMG-CoA Reductase HMGCR) inhibitors
SMILE Code: CN1CCCCCOC(C(OC)=C2)=CC3=C2N=CN=C3NC4=CC(Br)=CC=C4C1
Appearance: white solid powder
Purity: 98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.Web Site click
Storage Condition: Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO, not in water
Shelf Life: 2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 – 4 C for short term (days to weeks), or -20 C for long term (months).PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22128301
Chemical Formulaļ¼šC22H25BrN4O2
ExactMass: 456.11609
Molecular Weight: 457.3635
Elemental Analysis: C, 57.77; H, 5.51; Br, 17.47; N, 12.25; O, 7.00